Keros Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Keros Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q1 2024.
  • Keros Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $277K, a 65.9% increase year-over-year.
  • Keros Therapeutics, Inc. annual Depreciation for 2023 was $815K, a 20.9% increase from 2022.
  • Keros Therapeutics, Inc. annual Depreciation for 2022 was $674K, a 78.3% increase from 2021.
  • Keros Therapeutics, Inc. annual Depreciation for 2021 was $378K, a 36% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $277K +$110K +65.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 $167K +$54K +47.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $113K +$33K +41.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $80K +$17K +27% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $63K +$18K +40% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $45K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.